219 related articles for article (PubMed ID: 1406939)
1. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition.
Franzoso G; Bours V; Park S; Tomita-Yamaguchi M; Kelly K; Siebenlist U
Nature; 1992 Sep; 359(6393):339-42. PubMed ID: 1406939
[TBL] [Abstract][Full Text] [Related]
2. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B.
Wulczyn FG; Naumann M; Scheidereit C
Nature; 1992 Aug; 358(6387):597-9. PubMed ID: 1501714
[TBL] [Abstract][Full Text] [Related]
3. Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation.
Watanabe N; Iwamura T; Shinoda T; Fujita T
EMBO J; 1997 Jun; 16(12):3609-20. PubMed ID: 9218802
[TBL] [Abstract][Full Text] [Related]
4. Bcl-3, a member of the I kappa B proteins, has distinct specificity towards the Rel family of proteins.
Inoue J; Takahara T; Akizawa T; Hino O
Oncogene; 1993 Aug; 8(8):2067-73. PubMed ID: 8336935
[TBL] [Abstract][Full Text] [Related]
5. I kappa B alpha can localize in the nucleus but shows no direct transactivation potential.
Cressman DE; Taub R
Oncogene; 1993 Sep; 8(9):2567-73. PubMed ID: 8361766
[TBL] [Abstract][Full Text] [Related]
6. Human T cell leukemia virus type 1 tax protein increases NF-kappa B dimer formation and antagonizes the inhibitory activity of the I kappa B alpha regulatory protein.
Petropoulos L; Lin R; Hiscott J
Virology; 1996 Nov; 225(1):52-64. PubMed ID: 8918533
[TBL] [Abstract][Full Text] [Related]
7. Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR.
Seeler JS; Muchardt C; Podar M; Gaynor RB
Virology; 1993 Oct; 196(2):442-50. PubMed ID: 8372429
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kappa B activity.
Gribaudo G; Ravaglia S; Gaboli M; Gariglio M; Cavallo R; Landolfo S
Virology; 1995 Aug; 211(1):251-60. PubMed ID: 7645218
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.
Harhaj E; Blaney J; Millhouse S; Sun SC
Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004
[TBL] [Abstract][Full Text] [Related]
10. Suppression of signals required for activation of transcription factor NF-kappa B in cells constitutively expressing the HTLV-I Tax protein.
Ruben SM; Rosen CA
New Biol; 1990 Oct; 2(10):894-902. PubMed ID: 1964088
[TBL] [Abstract][Full Text] [Related]
11. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
[TBL] [Abstract][Full Text] [Related]
12. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
[TBL] [Abstract][Full Text] [Related]
13. Tax protein of HTLV-1 destabilizes the complexes of NF-kappa B and I kappa B-alpha and induces nuclear translocation of NF-kappa B for transcriptional activation.
Suzuki T; Hirai H; Murakami T; Yoshida M
Oncogene; 1995 Mar; 10(6):1199-207. PubMed ID: 7700645
[TBL] [Abstract][Full Text] [Related]
14. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
[TBL] [Abstract][Full Text] [Related]
15. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
Thornburg NJ; Pathmanathan R; Raab-Traub N
Cancer Res; 2003 Dec; 63(23):8293-301. PubMed ID: 14678988
[TBL] [Abstract][Full Text] [Related]
16. Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages.
Kuprash DV; Udalova IA; Turetskaya RL; Rice NR; Nedospasov SA
Oncogene; 1995 Jul; 11(1):97-106. PubMed ID: 7624137
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of E3330, a novel quinone derivative able to suppress tumor necrosis factor-alpha generation, on activation of nuclear factor-kappa B.
Goto M; Yamada K; Katayama K; Tanaka I
Mol Pharmacol; 1996 May; 49(5):860-73. PubMed ID: 8622636
[TBL] [Abstract][Full Text] [Related]
18. Insulin receptor substrate-3, interacting with Bcl-3, enhances p50 NF-kappaB activity.
Kabuta T; Hakuno F; Cho Y; Yamanaka D; Chida K; Asano T; Wada K; Takahashi S
Biochem Biophys Res Commun; 2010 Apr; 394(3):697-702. PubMed ID: 20226764
[TBL] [Abstract][Full Text] [Related]
19. The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.
Franzoso G; Bours V; Azarenko V; Park S; Tomita-Yamaguchi M; Kanno T; Brown K; Siebenlist U
EMBO J; 1993 Oct; 12(10):3893-901. PubMed ID: 8404857
[TBL] [Abstract][Full Text] [Related]
20. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
Hatada EN; Nieters A; Wulczyn FG; Naumann M; Meyer R; Nucifora G; McKeithan TW; Scheidereit C
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2489-93. PubMed ID: 1532257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
